• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

百日咳博德特氏菌蛋白脂质体可在小鼠中诱导产生保护作用,且不影响三价制剂中白喉类毒素和破伤风类毒素的免疫原性。

A Bordetella pertussis proteoliposome induces protection in mice without affecting the immunogenicity of diphtheria and tetanus toxoids in a trivalent formulation.

作者信息

Castillo Sonsire Fernández, Chovel Mario Landys, Hernández Niurka Gutiérrez, González Lorena Corcho, Blanco Amaya, Hernández Daily Serrano, Medina Mildrey Fariñas, Tito Maydelis Álvarez, Quiñoy José Luis Pérez

机构信息

Finlay Institute, Havana, Cuba.

Medical Faculty and Institute of Basic and Preclinical Science "Victoria de Girón", University of Medical Sciences of Havana, Havana, Cuba.

出版信息

Clin Exp Vaccine Res. 2016 Jul;5(2):175-8. doi: 10.7774/cevr.2016.5.2.175. Epub 2016 Jul 29.

DOI:10.7774/cevr.2016.5.2.175
PMID:27489808
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4969282/
Abstract

In this study, a formulation of Bordetella pertussis proteoliposome (PLBp), diphtheria, and tetanus toxoids and alum (DT-PLBp) was evaluated as a trivalent vaccine candidate in BALB/c mice. Vaccine-induced protection was estimated using the intranasal challenge for pertussis and enzyme-linked immunosorbent assay fvto assess serological responses for diphtheria or tetanus. Both, diphtheria-tetanus-whole cell pertussis (DTP) and diphtheria-tetanus vaccines (DT) were used as controls. Animals immunized with DT-PLBp, PLBp alone, and DTP showed total reduction of CFU in lungs 7 days after intranasal challenge. Likewise, formulations DT-PLBp, DTP, and DT elicited antibody levels ≥2 IU/mL against tetanus and diphtheria, considered protective when neutralization tests are used. Overall, results showed that combination of PLBp with tetanus and diphtheria toxoids did not affect the immunogenicity of each antigen alone.

摘要

在本研究中,评估了百日咳博德特氏菌蛋白脂质体(PLBp)、白喉和破伤风类毒素与明矾(DT-PLBp)的配方作为BALB/c小鼠三价疫苗候选物的效果。使用百日咳鼻内攻毒法评估疫苗诱导的保护作用,并使用酶联免疫吸附测定法评估对白喉或破伤风的血清学反应。白喉-破伤风-全细胞百日咳疫苗(DTP)和白喉-破伤风疫苗(DT)均用作对照。用DT-PLBp、单独的PLBp和DTP免疫的动物在鼻内攻毒7天后肺部的菌落形成单位(CFU)总数减少。同样,DT-PLBp、DTP和DT配方诱导的抗破伤风和白喉抗体水平≥2 IU/mL,在使用中和试验时被认为具有保护性。总体而言,结果表明PLBp与破伤风和白喉类毒素的组合不会影响每种抗原单独的免疫原性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e6/4969282/56a43d2a93e7/cevr-5-175-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e6/4969282/f8daccbf9ccb/cevr-5-175-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e6/4969282/56a43d2a93e7/cevr-5-175-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e6/4969282/f8daccbf9ccb/cevr-5-175-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e6/4969282/56a43d2a93e7/cevr-5-175-g002.jpg

相似文献

1
A Bordetella pertussis proteoliposome induces protection in mice without affecting the immunogenicity of diphtheria and tetanus toxoids in a trivalent formulation.百日咳博德特氏菌蛋白脂质体可在小鼠中诱导产生保护作用,且不影响三价制剂中白喉类毒素和破伤风类毒素的免疫原性。
Clin Exp Vaccine Res. 2016 Jul;5(2):175-8. doi: 10.7774/cevr.2016.5.2.175. Epub 2016 Jul 29.
2
Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection.礼来/武田无细胞百日咳成分白喉破伤风类毒素及百日咳疫苗(而非礼来全细胞成分白喉破伤风类毒素及百日咳疫苗)对副百日咳博德特氏菌感染的疗效证据。
Clin Infect Dis. 1999 Mar;28(3):602-4. doi: 10.1086/515154.
3
Comparison of the safety and immunogenicity of acellular (BIKEN) and whole-cell pertussis vaccines in 15- to 20-month-old children.15至20月龄儿童无细胞(比肯)百日咳疫苗与全细胞百日咳疫苗的安全性和免疫原性比较。
Am J Dis Child. 1993 Mar;147(3):290-4. doi: 10.1001/archpedi.1993.02160270052017.
4
Whole-cell Bordetella pertussis vaccine component modulates the mouse immune response to an unrelated soluble antigen.全细胞百日咳博德特氏菌疫苗成分可调节小鼠对无关可溶性抗原的免疫反应。
Microbes Infect. 2002 Jul;4(8):815-20. doi: 10.1016/s1286-4579(02)01601-5.
5
Clinical reactions and immunogenicity of the BIKEN acellular diphtheria and tetanus toxoids and pertussis vaccine in 4- through 6-year-old US children.美国4至6岁儿童使用BIKEN无细胞白喉破伤风类毒素及百日咳疫苗的临床反应和免疫原性
Am J Dis Child. 1992 May;146(5):556-9. doi: 10.1001/archpedi.1992.02160170036012.
6
Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.婴儿期接种的三组分无细胞百日咳疫苗在生命最初6年的持续效力:意大利的经验。
Pediatrics. 2001 Nov;108(5):E81. doi: 10.1542/peds.108.5.e81.
7
Alternative diphtheria, tetanus and whooping cough immunization schedule to evoke a Th2 tetanus and a Th1 pertussis immune response.用于引发Th2型破伤风免疫反应和Th1型百日咳免疫反应的白喉、破伤风和百日咳替代免疫程序。
Microbes Infect. 2004 Apr;6(5):481-4. doi: 10.1016/j.micinf.2004.01.004.
8
A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.两种无细胞百日咳疫苗和一种全细胞百日咳疫苗的对照试验。百日咳项目工作组。
N Engl J Med. 1996 Feb 8;334(6):341-8. doi: 10.1056/NEJM199602083340601.
9
A placebo-controlled trial of a pertussis-toxoid vaccine.一项百日咳类毒素疫苗的安慰剂对照试验。
N Engl J Med. 1995 Oct 19;333(16):1045-50. doi: 10.1056/NEJM199510193331604.
10
Pneumococcal Surface Protein A does not affect the immune responses to a combined diphtheria tetanus and pertussis vaccine in mice.肺炎球菌表面蛋白 A 不会影响小鼠对联合白喉破伤风和百日咳疫苗的免疫应答。
Vaccine. 2013 May 7;31(20):2465-70. doi: 10.1016/j.vaccine.2013.03.026. Epub 2013 Mar 26.

引用本文的文献

1
Dynamics and immunomodulation of cognitive deficits and behavioral changes in non-severe experimental malaria.非重症实验性疟疾认知缺陷和行为变化的动力学及免疫调节
Front Immunol. 2022 Nov 24;13:1021211. doi: 10.3389/fimmu.2022.1021211. eCollection 2022.
2
Immune system challenge improves recognition memory and reverses malaria-induced cognitive impairment in mice.免疫系统挑战可改善识别记忆,并逆转疟疾引起的小鼠认知障碍。
Sci Rep. 2021 Jul 21;11(1):14857. doi: 10.1038/s41598-021-94167-8.

本文引用的文献

1
Bacterial outer membrane vesicles and vaccine applications.细菌外膜囊泡及其疫苗应用。
Front Immunol. 2014 Mar 24;5:121. doi: 10.3389/fimmu.2014.00121. eCollection 2014.
2
Possible options for new pertussis vaccines.可能的新型百日咳疫苗选择。
J Infect Dis. 2014 Apr 1;209 Suppl 1:S24-7. doi: 10.1093/infdis/jit531.
3
A proteoliposome formulation derived from Bordetella pertussis induces protection in two murine challenge models.从百日咳博德特氏菌中提取的一种蛋白脂囊泡配方在两种小鼠挑战模型中诱导了保护作用。
BMC Immunol. 2013;14 Suppl 1(Suppl 1):S8. doi: 10.1186/1471-2172-14-S1-S8. Epub 2013 Feb 25.
4
Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin.百日咳再现:免疫减弱和病原体适应——同一枚硬币的两面。
Epidemiol Infect. 2014 Apr;142(4):685-94. doi: 10.1017/S0950268813000071. Epub 2013 Feb 13.
5
Why do pertussis vaccines fail?百日咳疫苗为何会失效?
Pediatrics. 2012 May;129(5):968-70. doi: 10.1542/peds.2011-2594. Epub 2012 Apr 23.
6
Pertussis vaccines: WHO position paper.百日咳疫苗:世界卫生组织立场文件。
Wkly Epidemiol Rec. 2010 Oct 1;85(40):385-400.
7
Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting.百日咳的预防:来自第二届全球百日咳倡议圆桌会议的建议。
Vaccine. 2007 Mar 30;25(14):2634-42. doi: 10.1016/j.vaccine.2006.12.017. Epub 2006 Dec 22.
8
Is there a need for a new generation of vaccines against pertussis?是否需要新一代的百日咳疫苗?
Expert Opin Emerg Drugs. 2006 May;11(2):195-205. doi: 10.1517/14728214.11.2.195.
9
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.百日咳博德特氏菌及其他博德特氏菌亚种引起的呼吸道感染的分子发病机制、流行病学及临床表现
Clin Microbiol Rev. 2005 Apr;18(2):326-82. doi: 10.1128/CMR.18.2.326-382.2005.
10
Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines.百日咳博德特氏菌感染的鼻内小鼠模型。I. 无细胞疫苗对人类婴儿保护作用的预测。
Vaccine. 1999 May 14;17(19):2366-76. doi: 10.1016/s0264-410x(99)00037-7.